Get the Stockscreener App
2.41
2.12%
0.05
Celularity Inc stock is traded at $2.41, with a volume of 79,366.
It is up +2.12% in the last 24 hours and down -26.75% over the past month.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
See More
Previous Close:
$2.36
Open:
$2.34
24h Volume:
79,366
Relative Volume:
0.33
Market Cap:
$57.72M
Revenue:
$48.20M
Net Income/Loss:
$-35.05M
P/E Ratio:
-1.5377
EPS:
-1.5673
Net Cash Flow:
$-13.02M
1W Performance:
-38.83%
1M Performance:
-26.75%
6M Performance:
+75.91%
1Y Performance:
-15.14%
1-Day Range:
$2.30
$2.44
1-Week Range:
$2.225
$3.1539
52-Week Range:
$1.06
$5.22
Celularity Inc Stock (CELU) Company Profile
Name
Celularity Inc
Sector
Industry
Phone
(908) 768-2170
Address
170 PARK AVE, FLORHAM PARK
Compare CELU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
2.41 | 62.99M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jun-22-22 | Initiated | H.C. Wainwright | Buy |
| Apr-06-22 | Downgrade | Truist | Buy → Hold |
| Jan-28-22 | Initiated | Oppenheimer | Outperform |
| Nov-24-21 | Initiated | Morgan Stanley | Equal-Weight |
View All
Celularity Inc Stock (CELU) Latest News
Published on: 2025-09-06 13:52:18 - Newser
Risk vs reward if holding onto Celularity Inc. Equity Warrant2025 Performance Recap & Accurate Entry and Exit Point Alerts - Newser
Celularity Inc. stock trend forecast2025 Geopolitical Influence & Low Risk Entry Point Tips - Newser
Key resistance and support levels for Celularity Inc. Equity WarrantWeekly Market Summary & Free Safe Entry Trade Signal Reports - Newser
Understanding Celularity Inc.’s price movement2025 Trading Volume Trends & Risk Managed Trade Strategies - Newser
Using Ichimoku Cloud for Celularity Inc. Equity Warrant technicalsAnalyst Downgrade & Verified Momentum Stock Ideas - Newser
What is Celularity Inc.’s TAM (Total Addressable Market)Earnings Performance Report & Fast Exit Strategy with Risk Control - خودرو بانک
Is Celularity Inc. being accumulated by smart moneyRate Hike & Long-Term Capital Growth Ideas - خودرو بانک
What is Celularity Inc. Equity Warrant’s book value per shareSell Signal & Daily Profit Maximizing Trade Tips - خودرو بانک
What is the earnings history of Celularity Inc. Equity WarrantRisk Management & Long Hold Capital Preservation Plans - خودرو بانک
What makes Celularity Inc. Equity Warrant stock price move sharplyExit Point & Long Hold Capital Preservation Plans - Newser
Can Celularity Inc. continue delivering strong returnsMarket Sentiment Report & Real-Time Volume Spike Alerts - خودرو بانک
Should I buy Celularity Inc. stock now2025 Price Targets & Weekly Sector Rotation Insights - خودرو بانک
Long term hold vs stop loss in Celularity Inc. Equity WarrantJuly 2025 Macro Moves & Weekly High Return Opportunities - Newser
Can Celularity Inc. Equity Warrant hit a new high this month2025 Market Outlook & Risk Managed Investment Signals - Newser
Will Celularity Inc. stock recover after earningsJuly 2025 Earnings & Accurate Intraday Trading Signals - خودرو بانک
Celularity Inc. Stock Performance After Earnings: Historical Insights2025 Price Targets & Expert Curated Trade Setup Alerts - Newser
Is Celularity Inc. reversing from oversold territory2025 Valuation Update & Community Supported Trade Ideas - Newser
What moving averages say about Celularity Inc. Equity WarrantPortfolio Performance Summary & Expert Verified Movement Alerts - Newser
Applying Wyckoff theory to Celularity Inc. stockWeekly Trade Review & Long-Term Safe Investment Plans - Newser
What earnings revisions data tells us about Celularity Inc. Equity WarrantWeekly Trade Review & Fast Moving Stock Trade Plans - Newser
What institutional flow reveals about Celularity Inc.Portfolio Profit Report & AI Based Buy/Sell Signal Reports - Newser
Will Celularity Inc. outperform its industry peersWeekly Risk Summary & AI Powered Trade Plan Recommendations - خودرو بانک
Using AI based signals to follow Celularity Inc.Portfolio Value Report & Daily Technical Stock Forecast Reports - Newser
Can Celularity Inc. Equity Warrant continue delivering strong returnsQuarterly Portfolio Summary & Scalable Portfolio Growth Methods - خودرو بانک
Will earnings trigger a reversal in Celularity Inc.July 2025 Snapshot & Safe Capital Allocation Plans - Newser
Can Celularity Inc. Equity Warrant scale operations efficiently2025 Support & Resistance & Reliable Intraday Trade Plans - خودرو بانک
Is a relief rally coming for Celularity Inc. Equity Warrant holdersWeekly Market Report & AI Enhanced Trade Execution Alerts - Newser
Celularity Inc. Equity Warrant stock trend outlook and recovery path2025 Performance Recap & Real-Time Volume Analysis - Newser
When is the best time to exit Celularity Inc. Equity WarrantJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
Chart based analysis of Celularity Inc. trendsWeekly Trend Report & Low Drawdown Investment Strategies - Newser
Multi asset correlation models including Celularity Inc.2025 Pullback Review & Expert Approved Momentum Ideas - Newser
What is the long term forecast for Celularity Inc. Equity Warrant stock2025 Investor Takeaways & Capital Protection Trading Alerts - خودرو بانک
Celularity Achieves Nasdaq Compliance with Recent Filing - The Globe and Mail
Published on: 2025-09-04 05:10:48 - Newser
Celularity Inc. Equity Warrant stock trend forecastTrade Exit Report & Fast Exit Strategy with Risk Control - Newser
Real time scanner hits for Celularity Inc. explainedAnalyst Downgrade & Weekly High Momentum Picks - Newser
Celularity Fulfills Nasdaq Listing Rule, Retires $41.6mln Debt, and Unveils Growth Plans - AInvest
Is it time to cut losses on Celularity Inc. Equity WarrantShare Buyback & Daily Volume Surge Trade Alerts - Newser
Can machine learning forecast Celularity Inc. recoveryShort Setup & Capital Efficient Trade Techniques - Newser
Will Celularity Inc. Equity Warrant see short term momentumBuy Signal & Community Verified Trade Alerts - Newser
Using data filters to optimize entry into Celularity Inc.Earnings Growth Report & Low Drawdown Investment Ideas - Newser
Order flow analysis tools used on Celularity Inc.CPI Data & Fast Gaining Stock Strategy Reports - Newser
Sentiment Recap: Can Celularity Inc. Equity Warrant outperform under higher oil pricesPortfolio Value Report & Reliable Breakout Stock Forecasts - خودرو بانک
Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance - Stock Titan
Celularity Files Q1 and Q2 2025 Form 10-Q Reports, Confirms Nasdaq Listing Rule Compliance - AInvest
Celularity Announces Filing of Form 10-Q Quarterly Reports - GlobeNewswire
Celularity Reports Q1 and Q2 Earnings, Complies with Nasdaq Listing Rules. - AInvest
Real time social sentiment graph for Celularity Inc.Earnings Trend Report & Safe Capital Allocation Plans - Newser
Analyzing recovery setups for Celularity Inc. investorsMarket Trend Summary & Reliable Entry Point Trade Alerts - Newser
What recovery options are there for Celularity Inc.Analyst Downgrade & Free Long-Term Investment Growth Plans - Newser
Celularity Inc Stock (CELU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Celularity Inc Stock (CELU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
| Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
| Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
| Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):